Clipping of news on Brazilian Culture, Law and Citizenship
10.20.2015
This article was translated by an automatic translation system, and was therefore not reviewed by people.
transparent image
Anvisa suspended the distribution, marketing and use of lot 1103866 drug Dramim B6 DL, injectable solution, 10ml. The product is manufactured by Takeda Pharma Ltda. and is valid until October 2016.
The determination took place after the manufacturer inform the Agency's voluntary recall of the batch of the product, which showed visible particles in the solution.
The measure is in Resolution 2,941 / 2015, published on Tuesday (20/10) in the Official Gazette (DOU).
Source: Anvisa
To access the Anvisa site, click here.
Our news are taken in full of our partner sites. For this reason, we can not change their content even in cases of typographical errors.
This article was translated by an automatic translation system, and was therefore not reviewed by people.